Search results

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.

View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.

Two startups supported by the nandin Innovation Centre at ANSTO have hit the ground running in 2021 securing major opportunities from state governments to see their businesses thrive.

Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia

Atomic structure of new cathode material for sodium ion batteries helps explain long life

ANSTO has almost seventy years of experience in advancing an understanding of the management of spent nuclear fuel and delivering safe and reliable forms for radioactive waste. 

A world-first processing technology developed in collaboration by ANSTO’s Minerals unit.

Launch of the second phase of construction of the underground laboratory to detect dark matter.

ANSTO’s Australian Synchrotron has been working on an initiative that could substantially improve radiotherapy treatment for cancer patients. 

Dr Richard Garrett featured on an ABC National program that highlighted how far we are from a future with nuclear fusion energy. Image: Jamison Daniel, Oak Ridge Leadership Computing Facility

A dedicated team of radiation specialists from the Australian Nuclear Science and Technology Organisation (ANSTO) are behind the successful detection and rapid retrieval of a missing radioactive source in outback Western Australia.

ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.

The radiography program focuses on the development of Neutron Capture Enhanced Particle Therapy (NCEPT) from initial preclinical work, to clinical trials and finally commercial translation and licencing.